Literature DB >> 3015919

Reconstitution of the muscarinic acetylcholine receptor. Guanine nucleotide-sensitive high affinity binding of agonists to purified muscarinic receptors reconstituted with GTP-binding proteins (Gi and Go).

K Haga, T Haga, A Ichiyama.   

Abstract

Muscarinic acetylcholine receptors purified from porcine brain were reconstituted with two kinds of GTP-binding proteins (Gi and Go). The binding of agonists was affected by guanine nucleotides when the receptor was reconstituted with either Gi or Go, but not in the absence of one of the GTP-binding proteins. The displacement curves with agonists for the [3H]quinuclidinyl benzylate [( 3H]QNB) binding were explained by assuming there are two sites with different affinities for a given agonist. The proportion of the high affinity site increased with increasing concentrations of the GTP-binding proteins, and the maximum value represented 50-70% of the total [3H]QNB-binding sites. Reconstitution of the receptor with both Gi and Go did not increase the proportion any further. These results indicate that Gi and Go interact with the same site, which rules out the possibility that there are two kinds of muscarinic receptors, one interacting with Gi and the other with Go. GDP as well as GTP decreased the affinity for the agonists of the muscarinic receptors reconstituted with Gi or Go. The conversion of GDP to GTP during the incubation was less than 1%, indicating that the effect of GDP is not due to its conversion to GTP, and that the binding of either GTP or GDP with the GTP-binding proteins suppresses their interaction with the receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015919

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Light-dependent GTP-binding proteins in squid photoreceptors.

Authors:  P R Robinson; S F Wood; E Z Szuts; A Fein; H E Hamm; J E Lisman
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

2.  Effects of guanine nucleotides on kainic acid binding and on adenylate cyclase in chick optic tectum and cerebellum.

Authors:  D O Souza; G Ramírez
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

Review 3.  Drugs and receptors. An overview of the current state of knowledge.

Authors:  T Kenakin
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

4.  Specific binding of [(3)H]17α,20β-dihydroxy-4-pregnen-3-one to oocyte cortices of rainbow trout (Oncorhynchus mykiss).

Authors:  M Yoshikuni; N Shibata; Y Nagahama
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

5.  A Gsalpha mutant designed to inhibit receptor signaling through Gs.

Authors:  T Iiri; S M Bell; T J Baranski; T Fujita; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

6.  Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.

Authors:  T Costa; A Herz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Coupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptor.

Authors:  Dar'ya S Redka; Takefumi Morizumi; Gwendolynne Elmslie; Pranavan Paranthaman; Rabindra V Shivnaraine; John Ellis; Oliver P Ernst; James W Wells
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

8.  Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.

Authors:  Rabindra V Shivnaraine; Xi-Ping Huang; Margaret Seidenberg; John Ellis; James W Wells
Journal:  Biochemistry       Date:  2012-05-24       Impact factor: 3.162

9.  Short-term desensitization of muscarinic K+ current in the heart.

Authors:  Shingo Murakami; Atsushi Inanobe; Yoshihisa Kurachi
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

10.  Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.

Authors:  Jan Jakubík; Alena Randáková; Esam E El-Fakahany; Vladimír Dolezal
Journal:  BMC Pharmacol       Date:  2009-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.